Skip to content
DraconiticResearch
Search Sources API
190,332 studies31 sourcesUpdated 5 min ago
Peer-reviewedCC BY 4.0Frontiers in Oncology

Grading and prognostic implications of tertiary lymphoid structures and CD155 expression in invasive breast carcinoma

Abstract

ObjectiveThis study investigated the distribution and maturity of tertiary lymphoid structures (TLS) in invasive breast carcinoma tissue, as well as their prognostic value for postoperative recurrence.MethodsThis study retrospectively collected tissue samples from 127 patients with invasive breast carcinoma at the Second People’s Hospital of Guangdong Province between January 2021 and December 2023. Immunohistochemistry was conducted to measure TLS and the expression of related proteins in invasive breast carcinoma and peritumoral tissues. Univariate and multivariate analyses were performed to determine the association between TLS and postoperative recurrence during the follow-up period. Receiver operating characteristic (ROC) curves were constructed to evaluate the discriminatory performance of TLS for postoperative recurrence.ResultsThe number and grade of TLS in invasive breast carcinoma tissue, as well as CD155 and Ki-67 expression, were markedly higher than those in peritumoral tissue. Compared with the non-recurrence group, patients in the recurrence group had a decreased number and grade of TLS in their tumor tissue and exhibited higher CD155 and Ki-67 expression intensity. Multivariate logistic regression analysis revealed that breast-conserving surgery, high CD155 expression, and high Ki-67 expression were independent positive predictors of postoperative recurrence, whereas a higher TLS grade was an independent negative predictor. TLS grade demonstrated moderate discriminatory performance, with an area under the ROC curve of 0.740, a sensitivity of 91.30%, and a specificity of 56.70%.ConclusionTLS presence in invasive breast carcinoma tissue and its maturity level are negatively associated with recurrence risk, serving as a potential prognostic marker for recurrence in patients with invasive breast carcinoma.

Related

  1. Prognostic and Spatial Organization of Tertiary Lymphoid Structures in Pancreatic Ductal Adenocarcinoma
    Yunqi Jia, Mengzhe Zhang, Haoran Yang +2
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Expression, prognostic association, and immune microenvironment correlates of C4orf50 in breast cancer: a The Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) bioinformatics study
    Sihang Lin, Lixia Liu, Jiayu Guan +4
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. RNF152 promoter methylation and gene expression in oral premalignant lesions and oral squamous cell carcinoma: implications for epigenetic biomarker development
    Madona Gjona, Seval Turna, Cömert Şen +6
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  4. Prognostic significance of EGFR-1 and VEGF-A expression in feline cutaneous squamous cell carcinoma.
    Laís Calazans Menescal Linhares, Marcelo Monte Mor Rangel, Krishna Duro de Oliveira +5
    Frontiers in veterinary sciencePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  5. Pheochromocytomas with Aggressive Histopathological Features Have Reduced Apelin and Increased VEGF Expression: Diagnostic and Prognostic Implications.
    Hatice Çalışkan Burgucu, Tuğba Günler, Ethem Ömeroğlu +2
    Pathophysiology : the official journal of the International Society for PathophysiologyPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
BibTeX
@article{yang2026grading,
  title = {{Grading and prognostic implications of tertiary lymphoid structures and CD155 expression in invasive breast carcinoma}},
  author = {Wenxin Yang and Yiming Li and Guiming Wang and Jinping Wang and Biling Zhong},
  journal = {Frontiers in Oncology},
  year = {2026},
  month = oct,
  doi = {10.3389/fonc.2026.1895307},
  url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1895307},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Grading and prognostic implications of tertiary lymphoid structures and CD155 expression in invasive breast carcinoma
AU  - Wenxin Yang
AU  - Yiming Li
AU  - Guiming Wang
AU  - Jinping Wang
AU  - Biling Zhong
PY  - 2026
DA  - 2026/10/30
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1895307
UR  - https://www.frontiersin.org/articles/10.3389/fonc.2026.1895307
AB  - ObjectiveThis study investigated the distribution and maturity of tertiary lymphoid structures (TLS) in invasive breast carcinoma tissue, as well as their prognostic value for postoperative recurrence.MethodsThis study retrospectively collected tissue samples from 127 patients with invasive breast carcinoma at the Second People’s Hospital of Guangdong Province between January 2021 and December 2023. Immunohistochemistry was conducted to measure TLS and the expression of related proteins in invasive breast carcinoma and peritumoral tissues. Univariate and multivariate analyses were performed to determine the association between TLS and postoperative recurrence during the follow-up period. Receiver operating characteristic (ROC) curves were constructed to evaluate the discriminatory performance of TLS for postoperative recurrence.ResultsThe number and grade of TLS in invasive breast carcinoma tissue, as well as CD155 and Ki-67 expression, were markedly higher than those in peritumoral tissue. Compared with the non-recurrence group, patients in the recurrence group had a decreased number and grade of TLS in their tumor tissue and exhibited higher CD155 and Ki-67 expression intensity. Multivariate logistic regression analysis revealed that breast-conserving surgery, high CD155 expression, and high Ki-67 expression were independent positive predictors of postoperative recurrence, whereas a higher TLS grade was an independent negative predictor. TLS grade demonstrated moderate discriminatory performance, with an area under the ROC curve of 0.740, a sensitivity of 91.30%, and a specificity of 56.70%.ConclusionTLS presence in invasive breast carcinoma tissue and its maturity level are negatively associated with recurrence risk, serving as a potential prognostic marker for recurrence in patients with invasive breast carcinoma.
SN  - 2234-943X
ER  -